Kristin Agopian, PhD

Kristin has been commercializing UCSF innovations for over 15 years and serves as head of the Licensing Team within Innovation Ventures. In this role, she leads the strategy and execution of technology licensing to both UCSF startups and established life sciences companies, while advancing company formation around breakthrough discoveries. She partners closely with inventors to shape commercialization pathways that maximize translational impact, market potential, and patient benefit across a portfolio spanning therapeutics, diagnostics, and medical devices.

She earned her Ph.D. in Virology from Harvard University and her A.B. in Molecular Biology from Princeton University. Prior to UCSF, she worked in biotechnology and pharmaceutical strategy consulting and contributed to science and technology policy at the National Academies.

Kristin is committed to advancing innovation at the interface of science and business, building enduring, mutually beneficial partnerships, and improving patients’ lives.